Listen "A ‘Revolution’ in drugging the undruggable hits a speed bump but motors on"
Episode Synopsis
Mark Goldsmith, Revolution Medicines Inc. president, CEO and chairman, talks about grappling with RAS mutations. Hosted on Acast. See acast.com/privacy for more information.